View
View
Do these cholesterol drugs help prevent strokes and heart problems?
Original Title
Primary and secondary prevention of stroke and cardiovascular events using evolocumab and alirocumab: Meta-analysis of randomized controlled trials.
doi:10.5414/CP20450638%
Lower Quality
Methodology score · 38/100
Meta Analysis Human
Fit Body Science breakdown
We translate health research into clear, actionable insights. Here’s what this study found and what it means for you.
Not medical advice. For informational purposes only. Always consult a healthcare professional.
What’s the bottom line?
Doctors wanted to know if two cholesterol drugs, evolocumab and alirocumab, help prevent strokes and heart issues in people at risk. They looked at many studies together to find out.
Score breakdown, methodology, COI, evidence analysis & raw study data